Gabriel A. De Erausquin, MD. PhD. - Publications

University of South Florida, Tampa, FL, United States 

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ortiz Alonso T, Santos JM, Ortiz Terán L, Borrego Hernández M, Poch Broto J, de Erausquin GA. Differences in Early Stages of Tactile ERP Temporal Sequence (P100) in Cortical Organization during Passive Tactile Stimulation in Children with Blindness and Controls. Plos One. 10: e0124527. PMID 26225827 DOI: 10.1371/journal.pone.0124527  0.6
2015 Arnedo J, Mamah D, Baranger DA, Harms MP, Barch DM, Svrakic DM, de Erausquin GA, Cloninger CR, Zwir I. Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy. Neuroimage. 120: 43-54. PMID 26151103 DOI: 10.1016/j.neuroimage.2015.06.083  0.6
2015 Kamis D, Stratton L, Calvó M, Padilla E, Florenzano N, Guerrero G, Molina Rangeon B, Molina J, de Erausquin GA. Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population. Schizophrenia Research. 164: 250-5. PMID 25735637 DOI: 10.1016/j.schres.2015.01.035  0.6
2015 Padilla E, Molina J, Kamis D, Calvo M, Stratton L, Strejilevich S, Aleman GG, Guerrero G, Bourdieu M, Conesa HA, Escobar JI, de Erausquin GA. The efficacy of targeted health agents education to reduce the duration of untreated psychosis in a rural population. Schizophrenia Research. 161: 184-7. PMID 25439394 DOI: 10.1016/j.schres.2014.10.039  0.6
2015 Arnedo J, Svrakic DM, Del Val C, Romero-Zaliz R, Hernández-Cuervo H, Fanous AH, Pato MT, Pato CN, de Erausquin GA, Cloninger CR, Zwir I. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. The American Journal of Psychiatry. 172: 139-53. PMID 25219520 DOI: 10.1176/appi.ajp.2014.14040435  0.6
2014 Alba-Ferrara L, Fernandez F, Salas R, de Erausquin GA. Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence. Addictive Disorders & Their Treatment. 13: 159-169. PMID 25598743 DOI: 10.1097/ADT.0b013e31829cf047  0.6
2014 Alba-Ferrara LM, Fernandez F, de Erausquin GA. The Use of Neuromodulation in the Treatment of Cocaine Dependence. Addictive Disorders & Their Treatment. 13: 1-7. PMID 24644430 DOI: 10.1097/ADT.0b013e31827b5a2c  0.6
2014 Ortiz T, Poch J, Santos JM, Martínez AM, Ortiz-Terán L, Requena C, Barcia JA, de Erausquin GA, Pascual-Leone A. Occipital cortex activation by long-term repetitive tactile stimulation is necessary for object recognition in blinds: a case report. Neurocase. 20: 273-82. PMID 23819463 DOI: 10.1080/13554794.2013.770878  0.6
2013 Arnedo J, del Val C, de Erausquin GA, Romero-Zaliz R, Svrakic D, Cloninger CR, Zwir I. PGMRA: a web server for (phenotype x genotype) many-to-many relation analysis in GWAS. Nucleic Acids Research. 41: W142-9. PMID 23761451 DOI: 10.1093/nar/gkt496  0.6
2013 Alba-Ferrara LM, de Erausquin GA. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Frontiers in Integrative Neuroscience. 7: 9. PMID 23483798 DOI: 10.3389/fnint.2013.00009  0.6
2013 Alba-Ferrara L, de Erausquin GA, Hirnstein M, Weis S, Hausmann M. Emotional prosody modulates attention in schizophrenia patients with hallucinations. Frontiers in Human Neuroscience. 7: 59. PMID 23459397 DOI: 10.3389/fnhum.2013.00059  0.6
2013 Alba-Ferrara L, de Erausquin GA. Demonstrating the pathophysiology of auditory hallucinations with transcranial magnetic stimulation Transcranial Magnetic Stimulation: Methods, Clinical Uses and Effects On the Brain. 109-118.  0.6
2013 De Erausquin GA, Alba-Ferrara L. rTMS in the treatment of major depression: Challenges and new directions Transcranial Magnetic Stimulation: Methods, Clinical Uses and Effects On the Brain. 131-150.  0.6
2012 Landreau F, Galeano P, Caltana LR, Masciotra L, Chertcoff A, Pontoriero A, Baumeister E, Amoroso M, Brusco HA, Tous MI, Savy VL, Lores Arnaiz Mdel R, de Erausquin GA. Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia. Plos One. 7: e51068. PMID 23251423 DOI: 10.1371/journal.pone.0051068  0.6
2011 O'Leary JC, Dharia S, Blair LJ, Brady S, Johnson AG, Peters M, Cheung-Flynn J, Cox MB, de Erausquin G, Weeber EJ, Jinwal UK, Dickey CA. A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. Plos One. 6: e24840. PMID 21935478 DOI: 10.1371/journal.pone.0024840  0.6
2011 Anastasía A, Wojnacki J, de Erausquin GA, Mascó DH. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease. Neuroscience. 195: 100-11. PMID 21871541 DOI: 10.1016/j.neuroscience.2011.08.019  0.6
2011 Ladaga GJ, Lezica FP, Barboni AM, Picos JA, de Erausquin GA. Pharmacokinetics of a single oral administration of cefalexin in mares and foals. The Veterinary Record. 168: 431a. PMID 21498439 DOI: 10.1136/vr.c6403  0.6
2011 Benítez BA, Belálcazar HM, Anastasía A, Mamah DT, Zorumski CF, Mascó DH, Herrera DG, de Erausquin GA. Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons. Neuropharmacology. 60: 1176-86. PMID 21044638 DOI: 10.1016/j.neuropharm.2010.10.024  0.6
2009 Alemán GG, de Erausquin GA, Micheli F. Cognitive disturbances in primary blepharospasm. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2112-20. PMID 19705473 DOI: 10.1002/mds.22736  0.6
2009 Anastasía A, Torre L, de Erausquin GA, Mascó DH. Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease. Journal of Neurochemistry. 109: 755-65. PMID 19245661 DOI: 10.1111/j.1471-4159.2009.06001.x  0.6
2009 Lezica FP, Filip R, Gorzalczany S, Ferraro G, de Erausquin GA, Rivas C, Ladaga GJ. Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse. Theriogenology. 71: 422-31. PMID 18823653 DOI: 10.1016/j.theriogenology.2008.08.010  0.6
2008 Zorumski CF, de Erausquin G, Dokucu M, Svrakic D, Garcia K, Jarvis M. Brain stimulation & the treatment of refractory psychiatric disorders. Missouri Medicine. 105: 57-61. PMID 18300607  0.6
2007 Tabbal SD, Revilla FJ, Mink JW, Schneider-Gibson P, Wernle AR, de Erausquin GA, Perlmutter JS, Rich KM, Dowling JL. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery. 61: 119-27; discussion 1. PMID 17876242 DOI: 10.1227/01.neu.0000289725.97211.51  0.6
2007 Anastasia A, de Erausquin GA, Wojnacki J, Mascó DH. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease. Journal of Neurochemistry. 103: 1542-52. PMID 17854351 DOI: 10.1111/j.1471-4159.2007.04856.x  0.6
2007 Ladaga GJ, Lezica FP, Ferraro G, De Erausquin GA. Some pharmacodynamic effects of eformoterol in the horse. Journal of Veterinary Pharmacology and Therapeutics. 30: 496-9. PMID 17803747 DOI: 10.1111/j.1365-2885.2007.00882.x  0.6
2007 Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Research. 89: 59-71. PMID 17071057 DOI: 10.1016/j.schres.2006.08.031  0.6
2006 Gonzalez Aleman G, Florenzano N, Padilla E, Bourdieu M, Guerrero G, Calvó M, Alberio G, Strejilevich S, de Erausquin GA. A 37-year-old woman with celiac disease, recurrent psychosis, and Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 729-31. PMID 16547920 DOI: 10.1002/mds.20853  0.6
2006 Dorsey DA, Mascó DH, Dikranian K, Hyrc K, Masciotra L, Faddis B, Soriano M, Gru AA, Goldberg MP, de Erausquin GA. Ultrastructural characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced cell death in embryonic dopaminergic neurons. Apoptosis : An International Journal On Programmed Cell Death. 11: 535-44. PMID 16532276 DOI: 10.1007/s10495-006-5268-y  0.6
2006 Calvó de Padilla M, Padilla E, González Alemán G, Bourdieu M, Guerrero G, Strejilevich S, Escobar JI, Svrakic N, Cloninger CR, de Erausquin GA. Temperament traits associated with risk of schizophrenia in an indigenous population of Argentina. Schizophrenia Research. 83: 299-302. PMID 16480854 DOI: 10.1016/j.schres.2005.12.848  0.6
2005 Strejilevich SA, Palatnik A, Avila R, Bustin J, Cassone J, Figueroa S, Gimenez M, de Erausquin GA. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Research. 133: 277-80. PMID 15741003 DOI: 10.1016/j.psychres.2004.10.009  0.6
2004 de Erausquin GA. Transactivation of cell death signals by glutamate transmission in dopaminergic neurons. Critical Reviews in Neurobiology. 16: 107-19. PMID 15581406 DOI: 10.1615/CritRevNeurobiol.v16.i12.120  0.6
2004 Zhang PL, Santos JM, Newcomer J, Pelfrey BA, Johnson MC, de Erausquin GA. Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients. Schizophrenia Research. 71: 137-44. PMID 15374581 DOI: 10.1016/j.schres.2003.11.005  0.6
2004 Moulder KL, Meeks JP, Shute AA, Hamilton CK, de Erausquin G, Mennerick S. Plastic elimination of functional glutamate release sites by depolarization. Neuron. 42: 423-35. PMID 15134639 DOI: 10.1016/S0896-6273(04)00184-9  0.6
2004 Yamada KA, Rensing N, Izumi Y, De Erausquin GA, Gazit V, Dorsey DA, Herrera DG. Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation. Pediatric Research. 55: 372-9. PMID 14681492 DOI: 10.1203/01.PDR.0000110523.07240.C1  0.6
2003 de Erausquin GA. [Mechanism of molecular action of neuroleptics]. Vertex (Buenos Aires, Argentina). 14: 36-44. PMID 12690408  0.6
2003 de Erausquin GA, Hyrc K, Dorsey DA, Mamah D, Dokucu M, Mascó DH, Walton T, Dikranian K, Soriano M, García Verdugo JM, Goldberg MP, Dugan LL. Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Molecular Pharmacology. 63: 784-90. PMID 12644578 DOI: 10.1124/mol.63.4.784  0.6
2002 De Erausquin GA. [Neurodevelopment and schizophrenia]. Vertex (Buenos Aires, Argentina). 13: 189-97. PMID 12404020  0.6
2000 Josh Hasbani M, Underhill SM, De Erausquin G, Goldberg MP. Synapse loss and regeneration: A mechanism for functional decline and recovery after cerebral ischemia? Neuroscientist. 6: 110-119.  0.6
1996 Isaacs KR, De Erausquin G, Strauss KI, Jacobowitz DM, Hanbauer I. Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures Molecular Brain Research. 36: 114-126. PMID 9011746 DOI: 10.1016/0169-328X(95)00252-N  0.6
1994 De Erausquin GA, Costa E, Hanbauer I. Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease. Pharmacological Reviews. 46: 467-82. PMID 7899474  0.6
1994 de Erausquin G, Brooker G, Costa E, Hanbauer I. Persistent AMPA receptor stimulation alters [Ca2+]i homeostasis in cultures of embryonic dopaminergic neurons Molecular Brain Research. 21: 303-311. PMID 7513376 DOI: 10.1016/0169-328X(94)90261-5  0.6
1993 Fohrman EB, de Erausquin G, Costa E, Wojcik WJ. Muscarinic m3 receptors and dynamics of intracellular Ca2+ cerebellar granule neurons European Journal of Pharmacology: Molecular Pharmacology. 245: 263-271. PMID 8101492 DOI: 10.1016/0922-4106(93)90106-J  0.6
1992 Faiman CP, de Erausquin GA, Baratti CM. Modulation of memory retrieval by pre-testing vasopressin: involvement of a central cholinergic nicotinic mechanism. Methods and Findings in Experimental and Clinical Pharmacology. 14: 607-13. PMID 1494301  0.6
1992 de Erausquin G, Brooker G, Hanbauer I. K+-evoked dopamine release depends on a cytosolic Ca2+ pool regulated by N-type Ca2+ channels Neuroscience Letters. 145: 121-125. PMID 1334537 DOI: 10.1016/0304-3940(92)90001-N  0.6
1992 De Erausquin G, Brooker G, Costa E, Wojcik WJ. Stimulation of high affinity γ-aminobutyric acidB receptors potentiates the depolarization-induced increase of intraneuronal ionized calcium content in cerebellar granule neurons Molecular Pharmacology. 42: 407-414. PMID 1328842  0.6
1991 Faiman CP, de Erausquin GA, Baratti CM. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms. Behavioral and Neural Biology. 56: 183-99. PMID 1759940 DOI: 10.1016/0163-1047(91)90592-E  0.6
1990 de Erausquin GA, Manev H, Guidotti A, Costa E, Brooker G. Gangliosides normalize distorted single-cell intracellular free Ca2+ dynamics after toxic doses of glutamate in cerebellar granule cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 8017-21. PMID 2236016  0.6
1990 Manev H, Favaron M, De Erausquin G, Guidotti A, Brooker G, Costa E. Destabilization of ionized Ca2+ homeostasis in excitatory amino acid neurotoxicity: antagonism by glycosphingolipids. Cell Biology International Reports. 14: 3-14. PMID 2185894 DOI: 10.1016/0309-1651(90)90066-8  0.6
1990 Baratti CM, de Erausquin GA, Faiman CP. Brain opioid peptides may participate in the reversal of pentylenetetrazol-induced amnesia. Methods and Findings in Experimental and Clinical Pharmacology. 12: 451-6. PMID 2087144  0.6
1989 Baratti CM, Faiman CP, de Erausquin GA. Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist. Behavioral and Neural Biology. 51: 424-35. PMID 2525022 DOI: 10.1016/S0163-1047(89)91065-0  0.6
1989 De Erausquin GA, Pitra JC, Bonnani Rey R, Faiman CP, B aratti CM. A novel-invasive method to measure skin potential response: Some pharmacological evidence Methods and Findings in Experimental and Clinical Pharmacology. 11: 765-770.  0.6
1988 Faiman CP, de Erausquin GA, Baratti CM. Vasopressin modulates the activity of nicotinic cholinergic mechanisms during memory retrieval in mice. Behavioral and Neural Biology. 50: 112-9. PMID 2900001 DOI: 10.1016/S0163-1047(88)90816-3  0.6
1987 Faiman CP, De Erausquin GA, Baratti CM. Mecamylamine prevents the enhancement of retention induced by lysine vasopressin in mice. Behavioral and Neural Biology. 48: 434-9. PMID 3689289 DOI: 10.1016/S0163-1047(87)90996-4  0.6
Show low-probability matches.